Recent Autoimmune Disease Diagnosis Market Analysis by The Business Research Company, Showcasing Future Industry

Autoimmune Disease Diagnosis Market Report Share

The Business Research Company

The Business Research Company’s Autoimmune Disease Diagnosis Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, November 4, 2026 /EINPresswire.com/ -- The landscape for diagnosing autoimmune diseases has seen substantial growth recently, driven by advances in technology and increasing awareness. As more people are affected by these complex conditions, the demand for accurate and timely diagnosis is rising. Let’s explore the current market size, key factors pushing growth, regional dominance, and notable trends shaping this sector.

Autoimmune Disease Diagnosis Market Size and Projected Growth
The autoimmune disease diagnosis market has experienced strong expansion and is projected to continue this trend in the near future. Market value is expected to rise from $6.2 billion in 2025 to $6.74 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.8%. This steady increase results from factors such as the rising prevalence of autoimmune disorders, broader availability of immunoassay technologies, growth of clinical laboratory networks, heightened awareness among physicians, and more widespread use of routine screening tests. Looking ahead, the market is forecasted to reach $9.38 billion by 2030, growing at a CAGR of 8.6%. This future growth is propelled by increasing demand for early and precise diagnosis, adoption of AI-assisted diagnostic tools, personalized diagnostic methods, expanded research funding, and the integration of point-of-care testing. Key developments expected during this period include greater utilization of advanced immunological tests, autoantibody panels, multiplex diagnostic platforms, enhanced laboratory automation, and a stronger emphasis on detecting diseases earlier.

Download a free sample of the autoimmune disease diagnosis market report:
https://thebusinessresearchcompany.com/sample_request?id=43616170&type=smp&name=Autoimmune%20Disease%20Diagnosis%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR

Understanding Autoimmune Disease Diagnosis and Its Scope
Autoimmune disease diagnosis involves identifying conditions where the immune system mistakenly targets and destroys healthy cells within the body. Common diseases under this category include Crohn's disease, rheumatoid arthritis, Hashimoto’s disease, multiple sclerosis, Grave’s disease, psoriasis, coeliac disease, type 1 diabetes, lupus, and inflammatory bowel syndrome. These illnesses are typically diagnosed using immunological testing methods that detect abnormal antibody production and immune responses. Accurate diagnosis enables tailored treatment plans and helps manage disease progression effectively.

Rising Incidence of Autoimmune Diseases as a Market Driver
One of the major factors fueling growth in the autoimmune disease diagnosis market is the increasing occurrence of autoimmune diseases worldwide. These disorders happen when the immune system turns against the body’s own healthy tissues, triggered by environmental factors like pollution, infections, and lifestyle shifts that disrupt immune regulation. Precise diagnosis plays a crucial role in identifying the specific immune disorder so that appropriate treatment can begin early and disease progression can be controlled. For example, in March 2023, the Society for Women’s Health Research, a U.S.-based non-profit organization, reported that the number of individuals affected by autoimmune diseases ranges between 23.5 million and 50 million. Global prevalence rates of these conditions are also rising annually by 3 to 9 percent. This growing burden of autoimmune diseases is a key driver behind the expanding demand for diagnostic solutions.

View the full autoimmune disease diagnosis market report:
https://thebusinessresearchcompany.com/report/Autoimmune-Disease-Diagnosis-Global-Market-Report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR

Impact of Increasing Healthcare Spending on Market Expansion
Another important influence on the autoimmune disease diagnosis market is the rise in healthcare expenditures. Healthcare spending represents the total financial resources devoted to medical products and services, serving as an indicator of a population’s health status and the efficiency of its healthcare system. When healthcare budgets increase, it enables quicker access to medical services, which improves disease identification, treatment, and patient outcomes. For example, in May 2024, the UK’s Office for National Statistics noted a 5.6% nominal increase in total healthcare expenditures from 2022 to 2023, a significant jump compared to just 0.9% growth in the previous year. This upward trend in healthcare funding supports the expansion of diagnostic capabilities and thus stimulates market growth.

North America Holds the Largest Share in Autoimmune Disease Diagnosis
In 2025, North America remained the leading region in the autoimmune disease diagnosis market, holding the largest market share. Western Europe ranked second in terms of market size. The market analysis includes other key regions such as Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive view of global market trends and regional growth opportunities.

What’s included in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X